Advanced systems for glucocorticoids' dermal delivery

Bibliography

• Bucks D. Skin structure and metabolism: relevance to the design of cutaneous therapeutics. Pharm Res 1984;1:148-53
   PubMedGoogle Scholar
• Cork MJ, Danby S, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Inves Dermatol 2009;129:1892-908
   PubMed Web of Science ®Google Scholar
• Elias PM. Epidermal lipids, barrier function and desquamation. J Invest Dermatol 1983;80:44-9
   PubMed Web of Science ®Google Scholar
• Madison KC. Barrier function of the skin: “La raison d´etre” of epidermis. J Invest Dermatol 2003;121(2):231-41
   PubMed Web of Science ®Google Scholar
• Wiedersberg S, Leopold CS, Guy RH. Bioavailability and bioequivalence of topical glucocorticoids. Eur J Pharm Biopham 2008;68(3):453-66
   PubMed Web of Science ®Google Scholar
• Vickers CF. Existence of reservoir in the SC. Arch Dermatol 1963;88:20-3
   PubMed Web of Science ®Google Scholar
• Trommer H, Neubert RH. Overcoming the SC: the modulation of skin penetration. A review. Skin Pharmacol Physiol 2006;19(2):106-21
   PubMed Web of Science ®Google Scholar
• Moser K, Kriwet K, Naik A, et al. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 2001;52:103-12
   PubMed Web of Science ®Google Scholar
• Scheuplein RJ. Permeability of the skin. Physiol Rev 1971;51:702-47
   PubMed Web of Science ®Google Scholar
• Santos P, Machado M, Watkinson AC, et al. The effect of drug concentration on solvent activity in silicone membranes. Int J Pharm 2009;377:70-5
   PubMed Web of Science ®Google Scholar
• Bolzinger M, Briançon S, Pelletier J, Chevalier Y. Penetration of drugs through skin, a complex rate-controlling membrane. Curr Opin Colloid Interface Sci 2012;17:156-65
   Web of Science ®Google Scholar
• Lademann J, Otberg N, Richter H, et al. Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol 2001;14(1):17-22
   PubMedGoogle Scholar
• Knorr F, Lademann J, Patzelt A, et al. Follicular transport route – research progress and future perspectives. Eur J Pharm Biopharm 2009;71:173-80
   PubMed Web of Science ®Google Scholar
• Patzelt A, Richter H, Knorr F, et al. Selective follicular targeting by modification of the particle sizes. J Control Release 2011;150:45-8
   PubMed Web of Science ®Google Scholar
• Lane M. Nanoparticles and the skin – applications and limitations. J Microencapsul 2011;28(8):709-16
   PubMed Web of Science ®Google Scholar
• Hadgraft J. Skin deep. Eur J Pharm Biopham 2004;58:291-9
   PubMed Web of Science ®Google Scholar
• Pirot F, Kalia NY, Stinchcomb AL, et al. Characterization of the permeability barrier of human skin in vivo. Proc Natl Acad Sci 1997;94:1562-7
   PubMed Web of Science ®Google Scholar
• Pellett M, Watkinson A, Hadgraft J, Brain K. Comparison of permeability data from traditional and ATR-FTIR spectroscopy part I. Synthetic membranes. Int J Pharm 1997;154:205-15
   Google Scholar
• Abraham W, Downing DT. Lamellar structures formed by SC lipids in vitro: a deuterium nuclear magnetic resonance (NMR) study. Pharm Res 1992;9:1415-21
   PubMed Web of Science ®Google Scholar
• Norlen L, Al-Almoudi A, Dubochet J. A cryotransmission electron microscopy study of skin barrier formation. J Invest Dermatol 2003;120:555-60
   PubMed Web of Science ®Google Scholar
• Essa EA, Bonner M, Barry BW. Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery. J Pharm Pharmacol 2002;54:1481-90
   PubMed Web of Science ®Google Scholar
• Sulzberger MB, Witten V. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 1952;19(2):101-2
   PubMed Web of Science ®Google Scholar
• Katz M, Gans EH. Topical corticosteroids, structure-activity and the glucocorticoid receptor: discovery and development—a process of “Planned Serendipity”. J Pharm Sci 2008;97(8):2936-47
   PubMed Web of Science ®Google Scholar
• Lagos BR, Maibach HI. Topical corticosteroids: unapproved uses, dosages, or indications. Clin Dermatol 2002;20:490-2
   PubMed Web of Science ®Google Scholar
• Available from: www.clinicaltrials.gov/ [Accessed on 30 November 2012]
   Google Scholar
• Montenegro L, Ademola J, Bonina F, Maibach H. Effect of application time of betamethasone- 17-valerate 0.1% cream on skin blanching and stratum corneum drug concentration. Int J Pharm 1996;140:51-60
   Web of Science ®Google Scholar
• Woodson JM. The Role of Low-Potency Topical Steroids in Day-to-Day Practice. Skin and Aging supplement of December 2009
   Google Scholar
• Shah V, Besancon L, Stolk P, et al. The pharmaceutical sciences in 2020: report of a conference organized by the board of pharmaceutical sciences of the international pharmaceutical federation (FIP). Pharma Res 2010;27:396-9
   Google Scholar
• Kerscher M, Williams S, Lehmann P. Topical treatment with glucocorticoids. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Springer-Verlag, Berlin; 1991. p. 483-4
   Google Scholar
• Ponec M. Glucocorticoid receptors. In: Korting HC, Maibach HI, editors. Topical glucocorticoids with increased benefit/risk ratio. Karger, Basel; 1993. p. 20-8
   Google Scholar
• Ahluwalia A. Topical glucocorticoids and the skin–mechanisms of action: an update. Mediat Inflamm 1998;7:183-93
   PubMed Web of Science ®Google Scholar
• Norris DA. Mechanisms of action of topical therapies and the rationale for combination therapy. J Am Acad Dermatol 2005;53(1):17-25
   Google Scholar
• Machado M, Salgado TM, Hadgraft J, Lane ME. The relationship between transepidermal water loss and skin permeability. Int J Pharm 2010;389:73-7
   Google Scholar
• Cevc G, Gebauer D. Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys J 2003;84:1010-24
   PubMed Web of Science ®Google Scholar
• Fini A, Bergamante V, Ceschel G. Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations. Pharm Sci Tech 2008;9:762-8
   Web of Science ®Google Scholar
• Katz M, Poulsen B. Corticoid, Vehicle, and skin interaction in percutaneous absorption. J Soc Cosmet Chem 1972;23:565-90
   Web of Science ®Google Scholar
• Cai X, Grant D, Wiedmann T. Analysis of the solubilization of steroids by bile salt micelles. J Pharm Sci 1997;86(3):372-7
   PubMed Web of Science ®Google Scholar
• Benson HA. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2005;2:23-33
   PubMedGoogle Scholar
• Alexander A, Dwivedi S, Ajazuddin et al. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release 2012;164:26-40
   PubMed Web of Science ®Google Scholar
• Ibrahim S, Li S. Chemical enhancer solubility in human stratum corneum lipids and enhancer mechanism of action on stratum corneum lipid domain. Int J Pharm 2010;383:89-98
   PubMed Web of Science ®Google Scholar
• Banga A, Bose S, Ghosh T. Iontophoresis and electroporation: comparison and contrasts. Int J Pharm 1999;179:1-19
   PubMed Web of Science ®Google Scholar
• Davis AF, Hadgraft J. Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate. Int J Pharm 1991;76:1-8
   Web of Science ®Google Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int J Pharm 2000;193:231-7
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 2004;1663:61-73
   PubMed Web of Science ®Google Scholar
• Senyiğit T, Tekmen I, Sönmez U, et al. Deoxycholate hydrogels of betamethasone-17-valerate intended for topical use: in vitro and in vivo evaluation. Int J Pharm 2011;403:123-9
   PubMed Web of Science ®Google Scholar
• Huang X, Tanojo H, Lenn J, et al. A novel foam vehicle for delivery of topical corticosteroids. J Am Acad Dermatol 2005;53:26-38
   PubMed Web of Science ®Google Scholar
• Fini A, Bergamante V, Ceschel G, et al. Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations. Pharm Sci Tech 2008;9:762-8
   Web of Science ®Google Scholar
• Mahalingam R, Li X, Jasti BR. Semisolid dosages: ointments, creams, and gels. In: Gad SC, editor. Pharmaceutical manufacturing handbook: production and processes. John Wiley & Sons, New Jersey; 2008. p. 267-312
   Google Scholar
• Salgado A, Silva A, Machado M, et al. Development, stability and in vitro permeation studies of gels containing mometasone furoate for the treatment of dermatitis of the scalp. Braz J Pharm Sci 2010;46:109-14
   Web of Science ®Google Scholar
• Patel RP, Kamani R. Formulation, optimization and evaluation of mometasone furoate gel. J Pharm Res 2009;2(12):1842-7
   Google Scholar
• Teng X, Cutler D, Davies N. Degradation kinetics of mometasone furoate in aqueous systems. Int J Pharm 2003;259:129-41
   PubMed Web of Science ®Google Scholar
• Senyiğit T, Padula C, Ozer O, Santi P. Different approaches for improving skin accumulation of topical corticosteroids. Int J Pharm 2009;380:155-60
   PubMed Web of Science ®Google Scholar
• Kim J, Choi HK. Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. Int J Pharm 2002;236:81-5
   PubMed Web of Science ®Google Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 2001;212:213-21
   PubMed Web of Science ®Google Scholar
• Eccleston GM. Emulsions and microemulsions. In: Swarbrick J, editor. Encyclopedia of pharmaceutical technology. Volume 3 Informa Healthcare USA, New York; 2006. p. 1548-79
   Google Scholar
• Ribeiro HM, Morais J, Eccleston GM. Structure and rheology of semisolid o/w creams. Int J Cosmetic Sci 2004;26:47-59
   PubMed Web of Science ®Google Scholar
• Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 2002;54(1):77-98
   Web of Science ®Google Scholar
• Borgia SL, Schlupp P, Mehnert W, Schäfer-Korting M. In vitro skin absorption and drug release – a comparison of six commercial prednicarbate preparations for topical use. Eur J Pharm Biopham 2008;68:380-9
   PubMed Web of Science ®Google Scholar
• Zulfakar M, Abdelouahab N, Heard CM. Enhanced topical delivery and ex vivo anti-inflammatory activity from a betamethasone dipropionate formulation containing fish oil. Inflamm Res 2010;59:23-30
   PubMed Web of Science ®Google Scholar
• Jung T, Stingl G. Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights. J Allergy Clin Immunol 2008;122:1074-81
   PubMed Web of Science ®Google Scholar
• Kim DH, Park WR, Kim JW, et al. Fabrication of pseudo-ceramide-based lipid microparticles for recovery of skin barrier function. Colloids Surf B 2012;94:236-41
   PubMed Web of Science ®Google Scholar
• Carneiro R, Salgado A, Raposo S, et al. Topical emulsions containing ceramides: effects on the skin barrier function and anti-inflammatory properties. Eur J Lipid Sci Technol 2011;113(8):961-6
   Web of Science ®Google Scholar
• Förster M, Bolzinger MA, Fessi H, Briançon S. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. Eur J Dermatol 2009;19(4):309-23
   PubMed Web of Science ®Google Scholar
• Savić A, Savić M, Tamburić S, et al. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation. Eur J Pharm Sci 2007;30:441-50
   PubMed Web of Science ®Google Scholar
• Baroli B, Lopez-Quintela MA, Delgado-Charro MB, et al. Microemulsions for topical delivery of eight-methoxsalen. J Control Release 2002;69:209-18
   Web of Science ®Google Scholar
• Kreilgaard M, Pedersen EJ, Jaroszewski JW. NMR characterization and trasdermal drug delivery potential of microemulsion systems. J Control Release 2000;69:421-33
   PubMed Web of Science ®Google Scholar
• Patel H, Barot B, Parejiya P. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: ex vivo permeation and skin irritation studies. Colloids Surf B 2013;102:86-94
   PubMed Web of Science ®Google Scholar
• Godin B, Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 2007;59:1152-61
   PubMed Web of Science ®Google Scholar
• Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol 1992;44:640-5
   PubMed Web of Science ®Google Scholar
• Lehmann L, Keipert S, Gloor M. Effects of microemulsions on the stratum corneum and hydrocortisone penetration. Eur J Pharm Biopharm 2001;52:129-36
   PubMed Web of Science ®Google Scholar
• Zhao Y, Brown MB, Jones SA. Pharmaceutical foams: are they the answer to the dilemma of topical nanoparticles? Nanomed Nanotechnol 2010;6:227-36
   PubMed Web of Science ®Google Scholar
• Stein L. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis. J Am Acad Dermatol 2005;53(1):39-49
   Google Scholar
• Franz TJ, Parsell DA, Halualani RM, et al. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy. Int J Dermatol 1999;38:628-32
   PubMed Web of Science ®Google Scholar
• Andreassi L, Giannetti A, Milani M. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients. Br J Dermatol 2003;148:134-8
   PubMed Web of Science ®Google Scholar
• Stein LF, Sherr A, Solodkina G, et al. Betamethasone valerate foam for treatment of nonscalp psoriasis. J Cutan Med Surg 2001;5:303-7
   PubMed Web of Science ®Google Scholar
• Franz TJ, Parsell DA, Myers JA, Hannigan JF. Clobetasol propionate foam 0.05%: a novel vehicle with enhanced delivery. Int J Dermatol 2000;39:535-8
   PubMed Web of Science ®Google Scholar
• Feldman SR, Ravis SM, Fleischer AB Jr, et al. Betamethasone valerate in foam vehicle is effective with both daily and twice a day dosing: a singleblind, open-label study in the treatment of scalp psoriasis. J Cutan Med Surg 2001;5:386-9
   PubMed Web of Science ®Google Scholar
• Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004;56:675-711
   PubMed Web of Science ®Google Scholar
• Wu X, Guy RH. Applications of nanoparticles in topical drug delivery and in cosmetics. J Drug Del Sci Tech 2009;19(6):371-84
   Web of Science ®Google Scholar
• Souto E, Almeida AJ, Müller RH. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. J Biom Nanotechnol 2007;3:317-31
   Web of Science ®Google Scholar
• Maia CS, Mehnert W, Schaller M, et al. Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002;10(6):489-95
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007;59:427-43
   PubMed Web of Science ®Google Scholar
• Müller R, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54(1):131-55
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009;366:170-84
   PubMed Web of Science ®Google Scholar
• Ochekpe NA, Olorunfemi PO, Ngwuluka NC. Nanotechnology and drug delivery, Part 2: nanostructures for drug delivery. Tropical J Pharm Res 2009;8:257-87
   Google Scholar
• Maia CS, Mehnert W, Schäfer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm 2000;196:165-7
   PubMed Web of Science ®Google Scholar
• Jores K, Mehnert W, Mäder K. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a Nuclear Magnetic Resonance and Electron Spin Resonance Study. Pharm Res 2003;20(8):1274-83
   PubMed Web of Science ®Google Scholar
• Sivaramakrishnan R, Nakamura C, Mehnert W, et al. Glucocorticoid entrapment into lipid carriers — characterization by parelectric spectroscopy and influence on dermal uptake. J Control Release 2004;97:493-502
   PubMed Web of Science ®Google Scholar
• Kumar V, Chandrasekar D, Ramakrishna S, et al. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm 2007;335:167-75
   PubMed Web of Science ®Google Scholar
• Reddy LH, Murthy RS. Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation. AAPS PharmSciTech 2005;6:158-66
   PubMed Web of Science ®Google Scholar
• Jensen LB, Magnussson E, Gunnarsson L, et al. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. Int J Pharm 2010;390:53-60
   PubMed Web of Science ®Google Scholar
• Zhang J, Smith E. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles. J Pharm Sci 2011;100:896-903
   PubMed Web of Science ®Google Scholar
• Schlupp P, Blaschke T, Kramer KD, et al. Drug Release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids. Skin Pharmacol Physiol 2011;24:199-209
   PubMed Web of Science ®Google Scholar
• Frum Y, Eccleston G, Meidan V. Factors influencing hydrocortisone permeation into human hair follicles: use of the skin sandwich system. Int J Pharm 2008;358:144-50
   PubMedGoogle Scholar
• Sarheed O, Frum Y. Use of the skin sandwich technique to probe the role of the hair follicles in Sonophoresis. Int J Pharm 2012;423:179-83
   PubMedGoogle Scholar
• Jensen LB, Petersson K, Nielsen HM. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. Eur J Pharm Biopharm 2011;79:68-75
   PubMed Web of Science ®Google Scholar
• Kalariya M, Padhi BK, Chougule M, Misra A. Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications. Indian J Exp Biol 2005;43(3):233-40
   PubMedGoogle Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Del Rev 2001;47:165-96
   PubMed Web of Science ®Google Scholar
• Westesen K, Bunjes H, Koch MHJ. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 1997;48:223-36
   Web of Science ®Google Scholar
• Westesen K, Siekmann B. Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int J Pharm 1997;151:35-45
   Web of Science ®Google Scholar
• Teeranachaideekul V, Boonme P, Souto EB, et al. Influence of oil content on physicochemical properties and skin distribution of nile red-loaded NLC. J Control Release 2008;128:134-41
   PubMed Web of Science ®Google Scholar
• Souto EB, Müller RH, Almeida AJ. Topical delivery of oily actives by means of solid lipid particles. Pharm Tech Europe 2007;19(12):28-32
   Google Scholar
• Doktorovová S, Araújo J, Garcia ML, et al. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf B 2010;75:538-42
   PubMed Web of Science ®Google Scholar
• Vitorino C, Sousa JJ, Almeida AJ, et al. Lipid nanoparticles as transdermal drug delivery systems: an in vitro/in vivo approach [abstract book]. 4th Symposium Skin & Formulation; Lyon, France; 2012. p. 49
   Google Scholar
• Barre RAG, Guy RH, Fessi H. Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur J Pharm Biopharm 2001;52:191-5
   PubMed Web of Science ®Google Scholar
• Lee PW, Peng SF, Su CJ, et al. The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials 2008;29:742-51
   PubMed Web of Science ®Google Scholar
• Grabnar PA, Kristl J. The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers. J Microencapsul 2011;28(4):323-35
   PubMed Web of Science ®Google Scholar
• Batheja P, Sheihet L, Kohn J, et al. Topical drug delivery by a polymeric nanosphere gel: formulation optimization and in vitro and in vivo skin distribution studies. J Controlled Release 2011;149:159-67
   PubMed Web of Science ®Google Scholar
• Senyiğit T, Sonvico F, Barbieri S, et al. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Control Release 2010;142:368-73
   PubMed Web of Science ®Google Scholar
• Abdel-Mottaleb M, Moulari B, Beduneau A, et al. Nanoparticles enhance therapeutic outcome in inflamed skin therapy. Eur J Pharm Biopharm 2012;82:151-7
   PubMed Web of Science ®Google Scholar
• Mezei M, Gulusekharam V. Liposomes, a selective drug delivery system for the topical route of administration. Life Sci 1982;26:1473-7
   Web of Science ®Google Scholar
• Mezei M, Gulusekharam V. Liposomes, a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 1982;34:473-4
   PubMed Web of Science ®Google Scholar
• Clares B, Gallardo V, Medina MM, Ruiz MA. Multilamellar liposomes of triamcinolone acetonide: preparation, stability, and characterization. J Liposome Res 2009;19(3):197-206
   PubMed Web of Science ®Google Scholar
• Wohlrab W, Lasch J. The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion. Dermatol Monatsschr 1989;175(6):348-52
   PubMedGoogle Scholar
• Egbaria K, Weiner N. Liposomes as a topical drug delivery system evaluated by in vitro diffusion studies. In: Gebelein CG, editor. Cosmetic and pharmaceutical applications of polymers. Plenum Press, NewYork; 1995. p. 215-24
   Google Scholar
• Harsanyi BB, Hilchie JC, Mezei M. Liposomes as drug carriers for oral ulcers. J Dent Res 1986;65(9):1133-41
   PubMed Web of Science ®Google Scholar
• Lasch J, Wohlrab W. Liposome-bound cortisol: a new approach to cutaneous therapy. Biomed Biochim Acta 1986;45(10):1295-9
   PubMedGoogle Scholar
• Korting HC, Zienicke H, Schäfer-Korting M, Braun-Falco O. Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 1990;39(4):349-51
   PubMed Web of Science ®Google Scholar
• Farshi FS, Ozer AY, Ercan MT, Hincal AA. In-vivo studies in the treatment of oral ulcers with liposomal dexamethasone sodium phosphate. J Microencapsul 1996;13(5):537-44
   PubMed Web of Science ®Google Scholar
• Richters CD, Paauw NJ, Mayen I, et al. Administration of prednisolone phosphate-liposomes reduces wound contraction in a rat partial-thickness wound model. Wound Repair Regen 2006;14(5):602-7
   PubMed Web of Science ®Google Scholar
• Kim MK, Chung SJ, Lee MH, Shim CK. Delivery of hydrocortisone from liposomal suspensions to the hairless mouse skin following topical application under non-occlusive and occlusive conditions. J Microencapsul 1998;15(1):21-9
   PubMed Web of Science ®Google Scholar
• Ashan F, Rivas IP, Khan MA, Suarez AIT. Targeting to macrophages: role of physicochemical properties of particulate carriers- liposomes and microspheres- on the phagocytosis by macrophages. J Control Release 2002;79:29-40
   PubMed Web of Science ®Google Scholar
• Bavarsad N, Fazly Bazzaz BS, Khamesipour A, Jaafari MR. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice. Acta Trop 2012;124:33-41
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers. transfersomes. Biochimica et Biophysica Acta 2003;1614:156-64
   PubMed Web of Science ®Google Scholar
• Simões SI. Veiculação transdérmica de fármacos: III. Promotores de transporte transdérmico de fármacos. Rev Bras Clin Terap 2001;27:257-74
   Google Scholar
• Simões S, Marques C, Cruz ME, Martins MBF. Anti-inflammatory effects of locally applied enzyme-loaded ultradeformable vesicles on an acute cutaneous model. J Microencapsul 2009;26:649-58
   PubMed Web of Science ®Google Scholar
• González-Paredes A, Manconi M, Caddeo C, et al. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study. J Liposome Res 2010;20(4):269-76
   PubMed Web of Science ®Google Scholar
• Fresta M, Puglisi G. Corticosteroid dermal delivery with skin-lipid liposomes. J Control Release 1997;44:141-51
   Web of Science ®Google Scholar
• Gillet A, Compère P, Lecomte F, et al. Liposome surface charge influence on skin penetration behaviour. Int J Pharm 2011;411:223-31
   PubMed Web of Science ®Google Scholar
• Gillet A, Lecomte F, Hubert P, et al. Skin penetration behaviour of liposomes as a function of their composition. Eur J Pharm Biopharm 2011;79(1):43-53
   PubMed Web of Science ®Google Scholar
• Lingan MA, Sathali AAH, Kumar MRV, Gokila A. Formulation and evaluation of topical drug delivery system containing clobetasol propionate niosomes. Sci Revs Chem Commun 2011;1(1):7-17
   Google Scholar
• Barry B.W. Transdermal drug delivery. Ch.12. In: Johnson P, Lloyd-Jones JG, editors. Drug delivery systems. Ellis Horwood, Chichester; 1987
   Google Scholar